View in EDS HTML Full Text PDF Full Text

LPL deletion is associated with poorer response to ibrutinib-based treatments and overall survival in TP53-deleted chronic lymphocytic leukemia.

Saved in:

Bibliographic Details
Title:	LPL deletion is associated with poorer response to ibrutinib-based treatments and overall survival in TP53-deleted chronic lymphocytic leukemia.
Authors:	Liu, Wei¹ (AUTHOR), Burger, Jan A.² (AUTHOR), Xu, Jie¹ (AUTHOR), Tang, Zhenya¹ (AUTHOR), Toruner, Gokce¹ (AUTHOR), Khanlari, Mahsa¹ (AUTHOR), Medeiros, L. Jeffrey¹ (AUTHOR), Tang, Guilin¹ (AUTHOR) gtang@mdanderson.org
Source:	Annals of Hematology. Oct2020, Vol. 99 Issue 10, p2343-2349. 7p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	09395555
DOI:	10.1007/s00277-020-04223-y